Search Results 421-430 of 11665 for Drug-resistant TB
The purpose of this study is to examine the effectiveness and safety of pembrolizumab as first line or above treatment in patients with metastatic triple- ...
The purpose of this study is to evaluate the effectiveness and safety of PANZYGA in pediatric patients with chronic Immune Thrombocytopenia (ITP). Participation ...
An alternative to this medication should be prescribed or you should stop breastfeeding while using this medicine. Drug Interactions. Although certain medicines ...
Peritoneal tuberculosis in an immunocompetent, unknown risk patient. ... Journal of Hematopathology. ... Thermophilic multidrug-resistant Campylobacter ...
Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...
The overall objective of this observational study is to characterize epidemiological, clinical, and biological features of adult patients hospitalized with ...
Factors Associated With Survival Following Radium-223 Treatment for Metastatic Castration-resistant Prostate Cancer. Clin Genitourin Cancer. 2017 Dec; 15(6): ...
... treatment of patients who have chronic lymphocytic leukemia that has returned or is resistant to treatment. Daratumumab for Chemotherapy-Refractory Minimal ...
Many of people don't get that much, and that can have serious consequences. On the next Mayo Clinic Radio, sleep medicine specialist Dr. Timothy Morgenthaler ...
The purpose of this study is to determine whether 2-drug therapy is non-inferior to 3-drug therapy against pulmonary mycobacterium avium complex (MAC) disease, ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.